THER Stock Chart & Stats
<$0.01
$0.00(0.00%)
At close: 4:00 PM EDT
<$0.01
$0.00(0.00%)
Day’s Range― - ―
52-Week Range<$0.01 - $0.02
Previous CloseN/A
Volume2.50K
Average Volume (3M)N/A
Market Cap
$6.15K
Enterprise Value$19.38M
Total Cash (Recent Filing)$998.28K
Total Debt (Recent Filing)$19.76M
Price to Earnings (P/E)―
Beta-55.93
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding6,151,500,000
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)>-0.01
Price to Sales (P/S)0.09
P/FCF Ratio>-0.01
Enterprise Value/Market Cap3.15K
Enterprise Value/Revenue25.70
Enterprise Value/Gross Profit32.93
Enterprise Value/Ebitda-2.47
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
THER FAQ
What was Theralink Technologies’s price range in the past 12 months?
Theralink Technologies lowest stock price was <$0.01 and its highest was $0.02 in the past 12 months.
What is Theralink Technologies’s market cap?
Theralink Technologies’s market cap is $6.15K.
When is Theralink Technologies’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Theralink Technologies’s earnings last quarter?
Currently, no data Available
Is Theralink Technologies overvalued?
According to Wall Street analysts Theralink Technologies’s price is currently Overvalued.
Does Theralink Technologies pay dividends?
Theralink Technologies does not currently pay dividends.
What is Theralink Technologies’s EPS estimate?
Theralink Technologies’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Theralink Technologies have?
Theralink Technologies has 6,151,500,000 shares outstanding.
What happened to Theralink Technologies’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Theralink Technologies?
Currently, no hedge funds are holding shares in THER
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Theralink Technologies
Theralink Technologies, Inc., headquartered in Golden, Colorado, is a commercial-stage enterprise specializing in precision medicine and the generation of crucial molecular data. The company is dedicated to advancing and bringing to market innovative cancer immunotherapy products. Utilizing its proprietary platform, which focuses on phosphoprotein and protein biomarkers, alongside its sophisticated laboratory-developed test (LDT) technology, Theralink addresses diverse aspects of oncology and pharmaceutical research. Through their specialized Theralink Reverse Phase Protein Array assays, they provide highly accurate oncology data. This information enables the biopharmaceutical industry and clinical oncologists to more precisely predict which patients will respond to, or be resistant to, both FDA-approved and investigational drug treatments. Ultimately, Theralink's diagnostic assays deliver vital, actionable insights that benefit physicians, patients, and biopharmaceutical companies operating within the field of cancer care. The company adopted its current name, Theralink Technologies, Inc., in September 2020, having previously operated as OncBioMune Pharmaceuticals, Inc.
Technical Analysis
Scinai Immunotherapeutics
―
NewcelX
―
Dermata Therapeutics
―
CDT Equity
―
Virax Biolabs Group Ltd. Class A
―